README.md · ncats/EpiSet4NER-v2 at 590c0e46cc3a9e45b696650c97e4c32c0db68005

metadata

annotations_creators:
  - machine-generated
  - expert-generated
language:
  - en
language_creators:
  - found
  - expert-generated
license:
  - other
multilinguality:
  - monolingual
pretty_name: EpiSet4NER-v2
size_categories:
  - 100K<n<1M
source_datasets:
  - original
tags:
  - epidemiology
  - rare disease
  - named entity recognition
  - NER
  - NIH
task_categories:
  - token-classification
task_ids:
  - named-entity-recognition

Dataset Description
Dataset Structure
Dataset Creation
Considerations for Using the Data
Additional Information

Dataset Description

Repository: Github
Paper: Pending

Dataset Summary

EpiSet4NER-v2 is a gold-standard dataset for epidemiological entity recognition of location, epidemiologic types (e.g. "prevalence", "annual incidence", "estimated occurrence"), and epidemiological rates (e.g. "1.7 per 1,000,000 live births", "2.1:1.000.000", "one in five million", "0.03%") created by the Genetic and Rare Diseases Information Center (GARD), a program in the National Center for Advancing Translational Sciences, one of the 27 National Institutes of Health. It was labeled programmatically using spaCy NER and rule-based methods, then manually validated by biomedical researchers, including a GARD curator (genetic and rare disease expert). This weakly-supervised teaching method allowed us to construct this high quality dataset in an efficient manner and achieve satisfactory performance on a multi-type token classification problem. It was used to train EpiExtract4GARD-v2, a BioBERT-based model fine-tuned for NER.

Data Fields

The data fields are the same among all splits.

id: a string feature that indicates sentence number.
tokens: a list of string features.
ner_tags: a list of classification labels, with possible values including O (0), B-LOC (1), I-LOC (2), B-EPI (3), I-EPI (4),B-STAT (5),I-STAT (6).

Data Splits

name	train	validation	test
EpiSet # of abstracts	456	114	50
EpiSet # tokens	117888	31262	13910

Dataset Creation

Figure 1: Creation of EpiSet4NER by NIH/NCATS Comparing the programmatically labeled test set to the manually corrected test set allowed us to measure the precision, recall, and F1 of the programmatic labeling.

Table 1: Programmatic labeling of EpiSet4NER

Evaluation Level	Entity	Precision	Recall	F1
Entity-Level	Overall	0.559	0.662	0.606
	Location	0.597	0.661	0.627
	Epidemiologic Type	0.854	0.911	0.882
	Epidemiologic Rate	0.175	0.255	0.207
Token-Level	Overall	0.805	0.710	0.755
	Location	0.868	0.713	0.783
	Epidemiologic Type	0.908	0.908	0.908
	Epidemiologic Rate	0.739	0.645	0.689

An example of the text labeling: Figure 2: Text Labeling using spaCy and rule-based labeling. Ideal labeling is bolded on the left. Actual programmatic output is on the right. [Figure citation]

Curation Rationale

To train ML/DL models that automate the process of rare disease epidemiological curation. This is crucial information to patients & families, researchers, grantors, and policy makers, primarily for funding purposes.

Source Data

620 rare disease abstracts classified as epidemiological by a LSTM RNN rare disease epi classifier from 488 diseases. See Figure 1.

Initial Data Collection and Normalization

A random sample of 500 disease names were gathered from a list of ~6061 rare diseases tracked by GARD until ≥50 abstracts had been returned for each disease or the EBI RESTful API results were exhausted. Though we called ~25,000 abstracts from PubMed's db, only 7699 unique abstracts were returned for 488 diseases. Out of 7699 abstracts, only 620 were classified as epidemiological by the LSTM RNN epidemiological classifier.

Annotations

Annotation process

Programmatic labeling. See here and then here. The test set was manually corrected after creation.

Who are the annotators?

Programmatic labeling was done by @William Kariampuzha, one of the NCATS researchers. The test set was manually corrected by 2 more NCATS researchers and a GARD curator (genetic and rare disease expert).

Personal and Sensitive Information

None. These are freely available abstracts from PubMed.

Considerations for Using the Data

Social Impact of Dataset

Assisting 25-30 millions Americans with rare diseases. Additionally can be useful for Orphanet or CDC researchers/curators.

Discussion of Biases and Limitations

There were errors in the source file that contained rare disease synonyms of names, which may have led to some unrelated abstracts being included in the training, validation, and test sets.
The abstracts were gathered through the EBI API and is thus subject to any biases that the EBI API had. The NCBI API returns very different results as shown by an API analysis here.
The long short-term memory recurrent neural network epi classifier was used to sift the 7699 rare disease abstracts. This model had a hold-out validation F1 score of 0.886 and a test F1 (which was compared against a GARD curator who used full-text articles to determine truth-value of epidemiological abstract) of 0.701. With 620 epi abstracts filtered from 7699 original rare disease abstracts, there are likely several false positives and false negative epi abstracts.
Tokenization was done by spaCy which may be a limitation (or not) for current and future models trained on this set.
The programmatic labeling was very imprecise as seen by Table 1. This is likely the largest limitation of the BioBERT-based model trained on this set.
The test set was difficult to validate even for general NCATS researchers, which is why we relied on a rare disease expert to verify our modifications. As this task of epidemiological information identification is quite difficult for non-expert humans to complete, this set, and especially a gold-standard dataset in the possible future, represents a challenging gauntlet for NLP systems, especially those focusing on numeracy, to compete on.

Additional Information

Dataset Curators

NIH GARD

Licensing Information

[More Information Needed]

Citation Information